Upgrade to SI Premium - Free Trial

Acadia Healthcare (ACHC) PT Raised to $90 at UBS on Emerging Substance Abuse Opportunity in the UK

August 6, 2015 8:17 AM
UBS analyst A.J. Rice reiterated a Buy rating and raised his price target on Acadia Healthcare (NASDAQ: ACHC) to $90.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles